SCHEMBL21091028

SCHEMBL21091028

Cc1cccc(/C(N)=N/N(C)N)c1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 1/20 0.38
▸ ESR2 Q92731 1/20 0.38
▸ MAPT P10636 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ TRPA1 O75762 2/20 0.36
▸ ATM Q13315 1/20 0.36
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ SIGMAR1 Q99720 2/20 0.33
▸ AKR1B10 O60218 1/20 0.33
▸ ABCB11 O95342 1/20 0.33
▸ DHFR P00374 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ MPO P05164 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CHRM1 P11229 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL102965 0.77 LMNA (0.43) ESR1ESR2MAPTALDH1A1TRPA1
SCHEMBL102966 0.77 LMNA (0.43) ESR1ESR2MAPTALDH1A1TRPA1
SCHEMBL674743 0.73 SIGMAR1 (0.41) ESR1ESR2MAPTALDH1A1TRPA1
SCHEMBL21091003 0.71 ESR1 (0.38) ESR1ESR2MAPTALDH1A1TRPA1
SCHEMBL21013799 0.70 ALDH1A1 (0.34) MAPTALDH1A1MEN1KMT2ANPC1
SCHEMBL8445208 0.69 TRPA1 (0.44) ESR1ESR2MAPTALDH1A1TRPA1
SCHEMBL4046937 0.69 TRPA1 (0.44) ESR1ESR2MAPTALDH1A1TRPA1
SCHEMBL160022 0.69 ESR1 (0.49) ESR1ESR2MAPTALDH1A1TRPA1
SCHEMBL6830746 0.69 TRPA1 (0.44) ESR1ESR2MAPTALDH1A1TRPA1
SCHEMBL6761818 0.69 MAPT (0.53) ESR1ESR2MAPTALDH1A1TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3495358-B1 AMIDE-SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES BRISTOL MYERS SQUIBB CO (US) 2022-04-27 — — EP disclosed
EP-3495358-A1 AMIDE-SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES Bristol-Myers Squibb Company (US) 2019-06-12 — — EP disclosed
Send feedback